agilon health, inc. (AGL)
After hours:
| Previous close | 6.75 |
| Open | 6.88 |
| Bid | 6.87 x 4000 |
| Ask | 6.94 x 1400 |
| Day's range | 6.56 - 6.94 |
| 52-week range | 4.41 - 21.52 |
| Volume | |
| Avg. volume | 4,455,711 |
| Market cap | 2.834B |
| Beta (5Y monthly) | 0.60 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.49 |
| Earnings date | 06 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 7.23 |
Business Wireagilon health Sets Date to Report Second Quarter 2024 Financial Results
AUSTIN, Texas, July 23, 2024--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the second quarter 2024 after the market closes on Tuesday, August 6, 2024, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results.
Business Wireagilon health Appoints Karthik Rao, M.D., as Chief Medical Officer
AUSTIN, Texas, July 10, 2024--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that after a comprehensive search Karthik Rao, M.D., who has served as agilon’s interim chief medical officer (CMO) since February 2024, has been appointed to the permanent CMO role, effective immediately. He previously served as senior medical director and vice president, network performance, at the company.
Business Wireagilon health Names Jeff Schwaneke New Chief Financial Officer
AUSTIN, Texas, June 05, 2024--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that Jeff Schwaneke, an experienced finance, operational and managed care executive and director on agilon’s board, will join the Company as chief financial officer and executive vice president effective July 1, 2024. He will be a member of agilon’s Executive Leadership team reporting to chief executive officer (CEO), Steve Sell. Sc
